A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in Healthy Children
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2007
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors MedImmune
- 01 Jul 2007 Results have been reported in the Pediatric Infectious Disease Journal.
- 12 Dec 2005 New trial record.